Bionomics Limited
NASDAQ:BNOX
0.6418 (USD) • At close September 18, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|
| Assets: | ||||||||
| Current Assets: | ||||||||
| Cash & Cash Equivalents
| 12.155 | 23.174 | 21.37 | 3.159 | 9.819 | 18.452 | 32.952 | 33.859 |
| Short Term Investments
| 0 | 0 | 0.327 | 0 | 0.386 | 0 | 0 | 0 |
| Cash and Short Term Investments
| 12.155 | 23.174 | 21.37 | 3.159 | 9.819 | 18.452 | 32.952 | 33.859 |
| Net Receivables
| 0.428 | 4.665 | 0.145 | 0.012 | 0.569 | 0.417 | 0.634 | 0.922 |
| Inventory
| -0.428 | -4.665 | 0 | 0 | 0.467 | 0.363 | 0.327 | 0.327 |
| Other Current Assets
| 1.229 | 5.693 | 1.676 | 2.579 | 6.79 | 7.354 | 7.958 | 8.164 |
| Total Current Assets
| 13.385 | 28.867 | 23.191 | 5.751 | 17.644 | 26.586 | 41.871 | 43.272 |
| Non-Current Assets: | ||||||||
| Property, Plant & Equipment, Net
| 0.335 | 0.466 | 0.653 | 0.728 | 1.76 | 2.031 | 2.012 | 2.112 |
| Goodwill
| 8.715 | 8.884 | 9.299 | 8.884 | 8.959 | 9.229 | 9.426 | 9.268 |
| Intangible Assets
| 6.129 | 6.793 | 7.458 | 8.12 | 9.038 | 10.027 | 11.014 | 11.966 |
| Goodwill and Intangible Assets
| 14.844 | 15.677 | 16.757 | 17.004 | 17.997 | 19.256 | 20.44 | 21.235 |
| Long Term Investments
| 0.079 | 0.082 | 0.089 | 0.3 | 0.269 | 0.284 | 0.295 | 0.286 |
| Tax Assets
| 15.099 | 16.061 | 17.32 | 17.432 | 19.488 | 21.004 | 22.158 | 23.061 |
| Other Non-Current Assets
| -15.179 | -16.143 | -17.41 | -17.732 | -19.758 | -21.287 | -22.452 | -23.347 |
| Total Non-Current Assets
| 15.179 | 16.143 | 17.41 | 17.732 | 19.758 | 21.287 | 22.452 | 23.347 |
| Total Assets
| 28.643 | 45.091 | 40.689 | 23.784 | 37.672 | 48.158 | 64.618 | 66.904 |
| Liabilities & Equity: | ||||||||
| Current Liabilities: | ||||||||
| Account Payables
| 1.374 | 1.075 | 0.771 | 0.871 | 0.844 | 2.67 | 1.46 | 1.962 |
| Short Term Debt
| 0.114 | 0.11 | 0.131 | 4.099 | 5.931 | 4.209 | 6.517 | 2.034 |
| Tax Payables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue
| -0.114 | -0.11 | -0.131 | -4.099 | 0.158 | -4.209 | 0.015 | 0.049 |
| Other Current Liabilities
| 1.377 | 1.242 | 0.999 | 4.838 | 2.756 | 7.163 | 2.682 | 4.438 |
| Total Current Liabilities
| 2.75 | 2.317 | 1.77 | 5.709 | 9.69 | 9.832 | 10.675 | 8.482 |
| Non-Current Liabilities: | ||||||||
| Long Term Debt
| 0.362 | 0.534 | 0.694 | 4.32 | 6.913 | 11.647 | 7.696 | 13.735 |
| Deferred Revenue Non-Current
| -0.362 | -0.534 | -0.694 | 2.803 | 4.851 | 9.428 | 4.037 | 9.917 |
| Deferred Tax Liabilities Non-Current
| 1.102 | 1.237 | 1.383 | 1.517 | 2.062 | 2.219 | 3.66 | 3.818 |
| Other Non-Current Liabilities
| 2.71 | 2.23 | 1.849 | -4.32 | -6.913 | -11.647 | -7.696 | -13.735 |
| Total Non-Current Liabilities
| 3.812 | 3.467 | 3.232 | 4.32 | 6.913 | 11.647 | 7.696 | 13.735 |
| Total Liabilities
| 6.565 | 5.798 | 4.998 | 15.032 | 26.088 | 35.607 | 33.527 | 34.005 |
| Equity: | ||||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock
| 148.803 | 150.301 | 142.614 | 102.247 | 101.758 | 100.075 | 103.402 | 100.118 |
| Retained Earnings
| -136.386 | -119.654 | -115.507 | -102.752 | -99.737 | -97.219 | -83.157 | -75.574 |
| Accumulated Other Comprehensive Income/Loss
| 9.656 | 8.612 | 8.595 | 9.235 | 9.558 | 9.678 | 10.825 | 8.351 |
| Other Total Stockholders Equity
| 0.006 | 0.035 | -0.01 | 0.022 | 0.004 | 0.017 | 0.022 | 0.004 |
| Total Shareholders Equity
| 22.078 | 39.294 | 35.691 | 8.752 | 11.583 | 12.551 | 31.092 | 32.9 |
| Total Equity
| 22.078 | 39.294 | 35.691 | 8.752 | 11.583 | 12.551 | 31.092 | 32.9 |
| Total Liabilities & Shareholders Equity
| 28.626 | 44.911 | 40.738 | 23.728 | 37.655 | 48.074 | 64.49 | 66.872 |